Phase I/II Study of LDE225 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Locally Advanced or Metastasized Pancreatic Cancer
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Sonidegib (Primary) ; Gemcitabine; Paclitaxel
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms MATRIX
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology
- 07 Jan 2020 Status changed from recruiting to completed.
- 12 Sep 2017 Results from phase I portion, presented at the 42nd European Society for Medical Oncology Congress.